China, Sept. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Analysis of the Application of Artificial Intelligence Technology in the Prospects of Primary Diabetic Retinopathy Screening'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132030
Registration Time: 2026/09/09
Type: Diagnostic test
Primary Sponsor: First Hospital of Nanping
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=332859
Published by HT Digital Content Services with permission from Health Daily Digest....